![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:1594679 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALYREF mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ALYREF mRNA | CTD | PMID:22206623 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of ALYREF mRNA | CTD | PMID:17023530 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ALYREF mRNA | CTD | PMID:21570461 | 3,4-methylenedioxymethamphetamine | decreases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ALYREF mRNA | CTD | PMID:20188158 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ALYREF mRNA | CTD | PMID:20188158 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1322669 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of ALYREF mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALYREF mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | RGD:1322669 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of ALYREF mRNA | CTD | PMID:28628672 | 6-propyl-2-thiouracil | increases expression | ISO | RGD:1594679 | 6480464 | Propylthiouracil results in increased expression of THOC4 mRNA | CTD | PMID:24780913 | acrylamide | decreases expression | ISO | RGD:1594679 | 6480464 | Acrylamide results in decreased expression of THOC4 mRNA | CTD | PMID:28959563 | atrazine | decreases expression | ISO | RGD:1322669 | 6480464 | Atrazine results in decreased expression of THOC4 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzoapyrene results in decreased expression of ALYREF mRNA | CTD | PMID:20504355 | bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of ALYREF mRNA | CTD | PMID:15674843 | bisphenol A | decreases expression | ISO | RGD:1594679 | 6480464 | bisphenol A results in decreased expression of THOC4 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | RGD:1322669 | 6480464 | bisphenol A results in decreased expression of ALYREF mRNA | CTD | PMID:29275510 | bisphenol A | increases methylation | ISO | RGD:1594679 | 6480464 | bisphenol A results in increased methylation of THOC4 gene | CTD | PMID:28505145 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of THOC4 promoter | CTD | PMID:27312807 | bisphenol F | multiple interactions | ISO | RGD:1322669 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALYREF mRNA | CTD | PMID:28628672 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chromium(6+) | affects expression | EXP | | 6480464 | chromium hexavalent ion affects the expression of ALYREF mRNA | CTD | PMID:28472532 | coumestrol | increases expression | ISO | RGD:1322669 | 6480464 | Coumestrol results in increased expression of ALYREF mRNA | CTD | PMID:19167446 | cyclophosphamide | decreases expression | EXP | | 6480464 | Cyclophosphamide results in decreased expression of ALYREF mRNA | CTD | PMID:21041162 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ALYREF mRNA | CTD | PMID:19770486 | DDT | increases methylation | ISO | RGD:1594679 | 6480464 | DDT results in increased methylation of ALYREF gene | CTD | PMID:30207508 | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of ALYREF mRNA | CTD | PMID:21041162 | dexamethasone | multiple interactions | ISO | RGD:1322669 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of ALYREF mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALYREF mRNA | CTD | PMID:28628672 | diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of ALYREF mRNA | CTD | PMID:21041162 | dioxygen | decreases expression | ISO | RGD:1322669 | 6480464 | Oxygen deficiency results in decreased expression of ALYREF mRNA | CTD | PMID:26516004 | folic acid | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ALYREF mRNA | CTD | PMID:22206623 | indometacin | multiple interactions | ISO | RGD:1322669 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of ALYREF mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ALYREF mRNA | CTD | PMID:28628672 | menadione | affects expression | ISO | RGD:1322669 | 6480464 | Vitamin K 3 affects the expression of ALYREF mRNA | CTD | PMID:20044591 | methapyrilene | increases expression | ISO | RGD:1594679 | 6480464 | Methapyrilene results in increased expression of ALYREF mRNA | CTD | PMID:30467583 | microcystin-LR | decreases expression | EXP | | 6480464 | cyanoginosin LR results in decreased expression of THOC4 protein | CTD | PMID:26984711 | nickel atom | increases expression | ISO | RGD:1322669 | 6480464 | Nickel results in increased expression of ALYREF mRNA | CTD | PMID:24768652, PMID:25583101 | nickel sulfate | increases expression | ISO | RGD:1322669 | 6480464 | nickel sulfate results in increased expression of THOC4 mRNA | CTD | PMID:22714537 | oxaliplatin | multiple interactions | ISO | RGD:1594679 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ALYREF mRNA | CTD | PMID:25729387 | paracetamol | affects response to substance | ISO | RGD:1322669 | 6480464 | ALYREF gene polymorphism affects the susceptibility to Acetaminophen | CTD | PMID:26104854 | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of ALYREF protein | CTD | PMID:25505154 | sodium arsenite | increases expression | ISO | RGD:1322669 | 6480464 | sodium arsenite results in increased expression of ALYREF mRNA | CTD | PMID:28595984 | sunitinib | decreases expression | ISO | RGD:1322669 | 6480464 | Sunitinib results in decreased expression of ALYREF mRNA | CTD | PMID:31533062 | tetrachloromethane | increases expression | ISO | RGD:1594679 | 6480464 | Carbon Tetrachloride results in increased expression of ALYREF mRNA | CTD | PMID:31150632 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of ALYREF mRNA | CTD | PMID:31919559 | tetrachloromethane | multiple interactions | ISO | RGD:1594679 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALYREF mRNA] | CTD | PMID:31150632 | topotecan | multiple interactions | ISO | RGD:1594679 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of ALYREF mRNA | CTD | PMID:25729387 | trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of ALYREF mRNA | CTD | PMID:19042947 | troglitazone | decreases expression | ISO | RGD:1322669 | 6480464 | troglitazone results in decreased expression of ALYREF mRNA | CTD | PMID:19140230 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ALYREF mRNA | CTD | PMID:17292431 | valproic acid | decreases expression | ISO | RGD:1322669 | 6480464 | Valproic Acid results in decreased expression of ALYREF mRNA | CTD | PMID:29154799 | valproic acid | affects expression | ISO | RGD:1322669 | 6480464 | Valproic Acid affects the expression of ALYREF mRNA | CTD | PMID:25979313 | valproic acid | increases methylation | ISO | RGD:1322669 | 6480464 | Valproic Acid results in increased methylation of ALYREF gene | CTD | PMID:29154799 | vinclozolin | increases expression | ISO | RGD:1594679 | 6480464 | vinclozolin results in increased expression of THOC4 mRNA | CTD | PMID:23034163 | Yessotoxin | decreases expression | ISO | RGD:1322669 | 6480464 | yessotoxin analog results in decreased expression of ALYREF mRNA | CTD | PMID:30679557 | |